Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

  • Ghostalmedia@lemmy.world
    link
    fedilink
    English
    arrow-up
    1
    ·
    1 year ago

    Although I wonder if HIPAA would need to get involved in places like the US if that happens. If that data is used to diagnose, then it falls under HIPAA.

    If they do that, there will definitely be giant legal battles. I wonder if that is a legal risk they’d want to take on.